Cancer staging in outcomes assessment
- 21 July 2014
- journal article
- review article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 110 (5) , 616-620
Abstract
The T N M staging system created by a surgeon in the 1950s continues to be a major benchmark for assessing long‐term outcomes in adult solid tumors. Although several major changes have occurred in this anatomical staging system, the tenets of TNM staging remain constant. Recently molecular markers and biologic modifiers have been added to this anatomical staging system to create a more robust outcomes tool. J. Surg. Oncol. 2014 110:616–620.Keywords
This publication has 20 references indexed in Scilit:
- Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaborationBMC Medicine, 2012
- A worldwide approach to the TNM staging system: Collaborative efforts of the AJCC and UICCJournal of Surgical Oncology, 2009
- Reporting colorectal cancerHistopathology, 2006
- Pathologic Staging of Colorectal CancerPathology Case Reviews, 2004
- New Tumor-Node-Metastasis Staging Strategy for Node-Positive (stage III) Rectal Cancer: An AnalysisJournal of Clinical Oncology, 2004
- The National Cancer Data Base: A clinical surveillance and quality improvement toolJournal of Surgical Oncology, 2003
- The process for continuous improvement of the TNM classificationCancer, 2003
- A New TNM Staging Strategy for Node-Positive (Stage III) Colon CancerAnnals of Surgery, 2002
- The TNM system: Our language for cancer careJournal of Surgical Oncology, 2002
- TNM residual tumor classification revisitedCancer, 2002